Innovent and Eli Lilly’s trial of TYVYT meets primary endpoint
The ORIENT-12 Phase III trial evaluated TYVYT, Gemzar and platinum chemotherapy combination to treat metastatic squamous non-small cell lung cancer. Credit: Nephron.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
KPS
Founded in 2010, KPS is a Functional Service Provider (FSP)...
About
Founded in 2010, KPS is a Functional Service Provider (FSP) offering Clinical Monitoring, Project Management and CRO Oversight solutions to the biopharmaceutical industry.
FollowMake an Enquiry
-
Experic
Experic is a contract manufacturing organization (CMO) and pharmaceutical supply...
About
Experic is a contract manufacturing organization (CMO) and pharmaceutical supply services company, which supports all stages of a product’s lifecycle from clinical to commercial scale.
FollowMake an Enquiry
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry